Printer Friendly

Dr. Reddya[euro](tm)s Laboratories unveils Amlodipine Besylate and Benazepril Hydrochloride capsules, 5 mg/40 mg and 10 mg/40 mg.

M2 EQUITYBITES-July 8, 2011-Dr. Reddya[euro](tm)s Laboratories unveils Amlodipine Besylate and Benazepril Hydrochloride capsules, 5 mg/40 mg and 10 mg/40 mg(C)2011 M2 COMMUNICATIONS http://www.m2.com

Pharmaceutical company Dr. Reddy's Laboratories (NYSE:RDY) revealed on Thursday the launch of its Amlodipine Besylate and Benazepril Hydrochloride capsules (5 mg/40 mg and 10 mg/40 mg) in the US market on 5 July 2011.

The company added the Amlodipine Besylate and Benazepril Hydrochloride capsules (5 mg/40 mg and 10 mg/40 mg) is the bio equivalent generic version of LOTREL capsules.

This US launch follows the United States Food & Drug Administration's (USFDA) approval of the company's ANDA for Amlodipine Besylate and Benazepril Hydrochloride capsules.

According to IMS Health, the LOTREL brand recorded US sales of approximately USD290m for the most recent 12 months ending March 2011

In addition, the company's Amlodipine Besylate and Benazepril Hydrochloride capsules 5 mg/40 mg and 10 mg/40 mg strengths are available in 100 count bottles.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2011 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jul 8, 2011
Words:180
Previous Article:Northumberland Resources announces first sale of oil from Pratt County Kansas oil project.
Next Article:-ICRA rates Hotel Sukhamaya's loans at D.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters